Anesth Analg 2003;96:1578-1583
© 2003 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
The Effect of Dexamethasone on Side Effects After Coronary Revascularization Procedures
Per Halvorsen, MD*,
Johan Ræder, MD PhD ,
Paul F. White, MD PhD ,
Sven M. Almdahl, MD PhD*,
Kenneth Nordstrand, MD PhD*,
Kjell Saatvedt, MD PhD*, and
Terje Veel, MD PhD*
*Departments of Anesthesiology and Surgery, Feiring Heart Clinic;
Department of Anesthesiology, Ullevaal University Hospital, Oslo, Norway; and
Department of Anesthesiology & Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
Address correspondence and reprint requests to Dr. P. F. White, Department of Anesthesiology & Pain Management, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9068. Address e-mail to paul.white{at}utsouthwestern.edu
Corticosteroids decrease side effects after noncardiac elective surgery. We designed this randomized, double-blinded, placebo-controlled study to test the hypothesis that standard doses of dexamethasone (4 mg x2) would reduce postoperative nausea, vomiting, and pain, decrease the incidence of atrial fibrillation (AF), and improve appetite after cardiac surgery, thereby facilitating the recovery process. A total of 300 patients undergoing coronary revascularization surgery were enrolled in this clinical study. The anesthetic management was standardized in all patients. Dexamethasone (4 mg/mL) or saline (1 mL) was administered after the induction of anesthesia and a second dose of the same study drug was given on the morning after surgery. The incidence of AF was determined by analyzing the first 72 h of continuously recorded electrocardiogram records after cardiac surgery. The patients were assessed at 24- and 48-h intervals after surgery, as well as at the time of hospital discharge, to determine the incidence and severity of postoperative side effects (e.g., nausea, vomiting, pain) and patient satisfaction scores. Dexamethasone significantly reduced the need for antiemetic rescue medication on the first postoperative day (30% versus 42%), and the incidences of nausea (15% versus 26%) and vomiting (5% versus 16%) on the second postoperative day (P < 0.05). In addition, dexamethasone significantly reduced the percentage of patients with a depressed appetite on the second postoperative day. However, the corticosteroid failed to decrease the incidence of AF (27% versus 32%) or the total dosage of opioid analgesic medication administered in the postoperative period. We conclude that dexamethasone (8 mg in divided doses) was beneficial in reducing emetic symptoms and improving appetite after cardiac surgery. However, this dose of the corticosteroid does not seem to have antiarrhythmic or analgesic-sparing properties.
IMPLICATIONS: Dexamethasone (8 mg IV) was beneficial in reducing emetic symptoms and increasing appetite after cardiac surgery. However, this dose of the corticosteroid failed to decrease postoperative pain or the incidence of new-onset atrial fibrillation.
This article has been cited by other articles:

|
 |

|
 |
 
J. Price, R. Tee, B.-K. Lam, P. Hendry, M. S. Green, and F. D. Rubens
Current use of prophylactic strategies for postoperative atrial fibrillation: a survey of Canadian cardiac surgeons.
Ann. Thorac. Surg.,
July 1, 2009;
88(1):
106 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anselmi, G. Possati, and M. Gaudino
Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation?
Ann. Thorac. Surg.,
July 1, 2009;
88(1):
326 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Ho and J. A. Tan
Benefits and Risks of Corticosteroid Prophylaxis in Adult Cardiac Surgery: A Dose-Response Meta-Analysis
Circulation,
April 14, 2009;
119(14):
1853 - 1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Whitlock, S. Chan, P.J. Devereaux, J. Sun, F. D. Rubens, K. Thorlund, and K. H.T. Teoh
Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials
Eur. Heart J.,
November 1, 2008;
29(21):
2592 - 2600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dorian and B. N. Singh
Upstream therapies to prevent atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2008;
10(suppl_H):
H11 - H31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. Kaljusto, K.-O. Stenslokken, T. Mori, A. Panchenko, M.-L. Frantzen, G. Valen, and J. Vaage
Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity
Eur. J. Cardiothorac. Surg.,
March 1, 2008;
33(3):
355 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Halonen, P. Halonen, O. Jarvinen, P. Taskinen, T. Auvinen, M. Tarkka, M. Hippelainen, T. Juvonen, J. Hartikainen, and T. Hakala
Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery: A Randomized Controlled Trial
JAMA,
April 11, 2007;
297(14):
1562 - 1567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Romundstad, H. Breivik, H. Roald, K. Skolleborg, T. Haugen, J. Narum, and A. Stubhaug
Methylprednisolone Reduces Pain, Emesis, and Fatigue After Breast Augmentation Surgery: A Single-Dose, Randomized, Parallel-Group Study with Methylprednisolone 125 mg, Parecoxib 40 mg, and Placebo
Anesth. Analg.,
February 1, 2006;
102(2):
418 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bianconi and L. Calo
Reply
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
468 - 468.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Prasongsukarn, J. G. Abel, W.R. E. Jamieson, A. Cheung, J. A. Russell, K. R. Walley, and S. V. Lichtenstein
The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial
J. Thorac. Cardiovasc. Surg.,
July 1, 2005;
130(1):
93 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishii, R. B. Schuessler, S. L. Gaynor, K. Yamada, A. S. Fu, J. P. Boineau, and R. J. Damiano Jr
Inflammation of Atrium After Cardiac Surgery Is Associated With Inhomogeneity of Atrial Conduction and Atrial Fibrillation
Circulation,
June 7, 2005;
111(22):
2881 - 2888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Burlacu, D. Healy, D. J. Buggy, C. Twomey, D. Veerasingam, A. Tierney, and D. C. Moriarty
Continuous Gastric Decompression for Postoperative Nausea and Vomiting After Coronary Revascularization Surgery
Anesth. Analg.,
February 1, 2005;
100(2):
321 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|